Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T Stamp A | IDAI | Apr 25, 2024 | 0.76 | -0.26 |
T-Mobile US | TMUS | Apr 25, 2024 | 164.05 | -0.08 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Apr 25, 2024 | 33.89 | -0.67 |
T. Rowe Price Dividend Growth ETF | TDVG | Apr 25, 2024 | 37.00 | +0.07 |
T. Rowe Price Equity Income ETF | TEQI | Apr 25, 2024 | 38.72 | -0.34 |
T. Rowe Price Group | TROW | Apr 25, 2024 | 108.83 | -2.01 |
T. Rowe Price Growth Stock ETF | TGRW | Apr 25, 2024 | 32.84 | -0.67 |
T2 Biosystems | TTOO | Apr 25, 2024 | 2.74 | -0.72 |
Taboola.com | TBLA | Apr 25, 2024 | 4.20 | +0.72 |
Tactile Systems Technology | TCMD | Apr 25, 2024 | 14.27 | -5.12 |
Taitron Components A | TAIT | Apr 25, 2024 | 3.16 | -0.63 |
Taiwan Fund | TWN | Apr 25, 2024 | 37.73 | +1.04 |
Taiwan Index MSCI Ishares | EWT | Apr 25, 2024 | 46.54 | +0.02 |
Taiwan Semiconductor Manufacturing ADR | TSM | Apr 25, 2024 | 136.58 | +2.71 |
Take-Two Interactive Software | TTWO | Apr 25, 2024 | 143.43 | +0.42 |
Takeda Pharmaceutical ADR | TAK | Apr 25, 2024 | 13.07 | -1.21 |
TAL Education Group ADR | TAL | Apr 25, 2024 | 13.35 | +8.89 |
Talis Biomedical | TLIS | Apr 25, 2024 | 9.00 | -2.18 |
Talkspace | TALK | Apr 25, 2024 | 3.08 | +0.33 |
Talos Energy | TALO | Apr 25, 2024 | 13.78 | +1.85 |
Talphera | TLPH | Apr 25, 2024 | 1.12 | 0.00 |
Tandem Diabetes Care | TNDM | Apr 25, 2024 | 35.56 | +1.25 |
Tanger | SKT | Apr 25, 2024 | 28.67 | +0.07 |
Tango Therapeutics | TNGX | Apr 25, 2024 | 7.33 | -5.54 |
Tantech | TANH | Apr 25, 2024 | 0.56 | 0.00 |
Taoping | TAOP | Apr 25, 2024 | 1.04 | -1.88 |
Tapestry | TPR | Apr 25, 2024 | 39.39 | -1.60 |
Targa Resources | TRGP | Apr 25, 2024 | 117.68 | +0.67 |
Target | TGT | Apr 25, 2024 | 164.44 | -0.54 |
Target Global Acquisition I A | TGAA | Apr 25, 2024 | 11.20 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.